Cargando…

MiRNA-mediated EMT and CSCs in cancer chemoresistance

Cancer stem cells (CSCs) are a small group of cancer cells, which contribute to tumorigenesis and cancer progression. Cancer cells undergoing epithelial-to-mesenchymal transition (EMT) acquire the chemoresistant ability, which is regarded as an important feature of CSCs. Thus, there emerges an opini...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Bing, Li, Shiyu, Zhu, Shuangli, Yi, Ming, Luo, Suxia, Wu, Kongming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881653/
https://www.ncbi.nlm.nih.gov/pubmed/33579377
http://dx.doi.org/10.1186/s40164-021-00206-5
_version_ 1783650922540302336
author Dong, Bing
Li, Shiyu
Zhu, Shuangli
Yi, Ming
Luo, Suxia
Wu, Kongming
author_facet Dong, Bing
Li, Shiyu
Zhu, Shuangli
Yi, Ming
Luo, Suxia
Wu, Kongming
author_sort Dong, Bing
collection PubMed
description Cancer stem cells (CSCs) are a small group of cancer cells, which contribute to tumorigenesis and cancer progression. Cancer cells undergoing epithelial-to-mesenchymal transition (EMT) acquire the chemoresistant ability, which is regarded as an important feature of CSCs. Thus, there emerges an opinion that the generation of CSCs is considered to be driven by EMT. In this complex process, microRNAs (miRNAs) are found to play a key role. In order to overcome the drug resistance, inhibiting EMT as well as CSCs phenotype seem feasible. Thereinto, regulating the EMT- or CSCs-associated miRNAs is a crucial approach. Herein, we conduct this review to elaborate on the complicated interplay between EMT and CSCs in cancer chemoresistance, which is modulated by miRNAs. In addition, we elucidate the therapeutic strategy to overcome drug resistance through targeting EMT and CSCs.
format Online
Article
Text
id pubmed-7881653
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-78816532021-02-17 MiRNA-mediated EMT and CSCs in cancer chemoresistance Dong, Bing Li, Shiyu Zhu, Shuangli Yi, Ming Luo, Suxia Wu, Kongming Exp Hematol Oncol Review Cancer stem cells (CSCs) are a small group of cancer cells, which contribute to tumorigenesis and cancer progression. Cancer cells undergoing epithelial-to-mesenchymal transition (EMT) acquire the chemoresistant ability, which is regarded as an important feature of CSCs. Thus, there emerges an opinion that the generation of CSCs is considered to be driven by EMT. In this complex process, microRNAs (miRNAs) are found to play a key role. In order to overcome the drug resistance, inhibiting EMT as well as CSCs phenotype seem feasible. Thereinto, regulating the EMT- or CSCs-associated miRNAs is a crucial approach. Herein, we conduct this review to elaborate on the complicated interplay between EMT and CSCs in cancer chemoresistance, which is modulated by miRNAs. In addition, we elucidate the therapeutic strategy to overcome drug resistance through targeting EMT and CSCs. BioMed Central 2021-02-12 /pmc/articles/PMC7881653/ /pubmed/33579377 http://dx.doi.org/10.1186/s40164-021-00206-5 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Review
Dong, Bing
Li, Shiyu
Zhu, Shuangli
Yi, Ming
Luo, Suxia
Wu, Kongming
MiRNA-mediated EMT and CSCs in cancer chemoresistance
title MiRNA-mediated EMT and CSCs in cancer chemoresistance
title_full MiRNA-mediated EMT and CSCs in cancer chemoresistance
title_fullStr MiRNA-mediated EMT and CSCs in cancer chemoresistance
title_full_unstemmed MiRNA-mediated EMT and CSCs in cancer chemoresistance
title_short MiRNA-mediated EMT and CSCs in cancer chemoresistance
title_sort mirna-mediated emt and cscs in cancer chemoresistance
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881653/
https://www.ncbi.nlm.nih.gov/pubmed/33579377
http://dx.doi.org/10.1186/s40164-021-00206-5
work_keys_str_mv AT dongbing mirnamediatedemtandcscsincancerchemoresistance
AT lishiyu mirnamediatedemtandcscsincancerchemoresistance
AT zhushuangli mirnamediatedemtandcscsincancerchemoresistance
AT yiming mirnamediatedemtandcscsincancerchemoresistance
AT luosuxia mirnamediatedemtandcscsincancerchemoresistance
AT wukongming mirnamediatedemtandcscsincancerchemoresistance